Showing results (2431-2440 of 5,263) with videos related to
Sort By:
Pageof 527
Oncology|March 18, 2021
Predictors of Nodal Pathological Complete Response in Asian Women with Stage II-III Node-Positive Breast CancerGiacomo Montagna, Yiwei Tong, Mathilde Ritter, et al.Oncology|January 1, 1987
Phase I-II trial of aclacinomycin A given in a four-consecutive-day schedule to patients with solid tumours. A South-East European Oncology Group (SEEOG) StudyS Kerpel-Fronius, F Gyergyay, I Hindy, et al.Oncology|January 1, 1987
Reversal of human myeloid leukemia cells into normal granulocytes and macrophages: activity and intracellular distribution of catalaseZ Kos, L Pavelić, B Pekić, et al.Oncology|January 1, 1987
Evaluating human choriogonadotropin heterogeneity in nongestational malignancy with monoclonal immunoassaysD L Hay, J R MurphyOncology|January 10, 2014
Reduced organic anion transporter expression is a risk factor for hepatocellular carcinoma in chronic hepatitis C patients: a propensity score matching studyYutaka Yasui, Atsushi Kudo, Masayuki Kurosaki, et al.Oncology|January 10, 2014
Reassessing hepatocellular carcinoma staging in a changing patient populationAhmed O Kaseb, Neeraj N Shah, Hesham M Hassabo, et al.Oncology|January 1, 1990
In vivo response of mitoxantrone and doxorubicin with dipyrone in parental and doxorubicin-resistant P388 leukemiaN S Kamath, M P ChitnisOncology|January 25, 2014
Clinical significance of epithelial-mesenchymal transition-associated markers in malignant pleural mesotheliomaTakashi Iwanami, Hidetaka Uramoto, Makoto Nakagawa, et al.Oncology|November 7, 2012
Multimodality treatment of gynecomastia in patients receiving antiandrogen therapy for prostate cancer in the era of abiraterone acetate and new antiandrogen moleculesDaniele Alesini, Roberto Iacovelli, Antonella Palazzo, et al.Oncology|November 7, 2012
Mammalian target of rapamycin as a rational therapeutic target for breast cancer treatmentPatricia Mucci LoRussoPageof 527